Literature DB >> 31006555

Chagas disease as example of a reemerging parasite.

Jeannette Guarner1.   

Abstract

Trypanosoma cruzi, the protozoan that causes Chagas disease, is primarily transmitted by three main Triatomine vectors in endemic areas. However, the infection has become a potential emerging disease because the vector is found in non-endemic areas, there is migration of infected asymptomatic people that can infect the vector, become blood donors, or pass the disease vertically (congenital infections). Lastly, the disease can be acquired through contaminated food (oral transmission). This review will present the different transmission pathways, clinical manifestations, diagnostic modalities and treatment considerations of Chagas disease.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Chagas disease; Trypanosoma cruzi

Mesh:

Year:  2019        PMID: 31006555     DOI: 10.1053/j.semdp.2019.04.008

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  7 in total

Review 1.  Worldwide Control and Management of Chagas Disease in a New Era of Globalization: a Close Look at Congenital Trypanosoma cruzi Infection.

Authors:  Carmen Muñoz; Montserrat Gállego; Alba Abras; Cristina Ballart; Anna Fernández-Arévalo; María-Jesús Pinazo; Joaquim Gascón
Journal:  Clin Microbiol Rev       Date:  2022-03-03       Impact factor: 50.129

Review 2.  Resveratrol and Curcumin for Chagas Disease Treatment-A Systematic Review.

Authors:  Carlos Henrique Lima Imperador; Cauê Benito Scarim; Priscila Longhin Bosquesi; Juliana Romano Lopes; Augusto Cardinalli Neto; Jeanine Giarolla; Elizabeth Igne Ferreira; Jean Leandro Dos Santos; Chung Man Chin
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-15

Review 3.  Selenium and protozoan parasitic infections: selenocompounds and selenoproteins potential.

Authors:  Sajad Rashidi; Celia Fernández-Rubio; Reza Mansouri; Mohammad Ali-Hassanzadeh; Esmaeel Ghani; Mohammadreza Karimazar; Raúl Manzano-Román; Paul Nguewa
Journal:  Parasitol Res       Date:  2022-01-06       Impact factor: 2.289

4.  In vitro anti-Trypanosoma cruzi activity enhancement of curcumin by its monoketone tetramethoxy analog diveratralacetone.

Authors:  Julia M Souza; Tatiana M Vieira; Ana Carolina B B Candido; Daiane Y Tezuka; G Subba Rao; Sérgio de Albuquerque; Antônio E M Crotti; Jair L Siqueira-Neto; Lizandra G Magalhães
Journal:  Curr Res Parasitol Vector Borne Dis       Date:  2021-05-31

5.  Induction of Autophagy by Ursolic Acid Promotes the Elimination of Trypanosoma cruzi Amastigotes From Macrophages and Cardiac Cells.

Authors:  María Cristina Vanrell; Santiago José Martinez; Lucila Ibel Muñoz; Betiana Nebaí Salassa; Julián Gambarte Tudela; Patricia Silvia Romano
Journal:  Front Cell Infect Microbiol       Date:  2022-07-08       Impact factor: 6.073

6.  Acrylonitrile Derivatives against Trypanosoma cruzi: In Vitro Activity and Programmed Cell Death Study.

Authors:  Carlos J Bethencourt-Estrella; Samuel Delgado-Hernández; Atteneri López-Arencibia; Desirée San Nicolás-Hernández; Ines Sifaoui; David Tejedor; Fernando García-Tellado; Jacob Lorenzo-Morales; José E Piñero
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-09

Review 7.  The Glycan Structure of T. cruzi mucins Depends on the Host. Insights on the Chameleonic Galactose.

Authors:  María Eugenia Giorgi; Rosa M de Lederkremer
Journal:  Molecules       Date:  2020-08-27       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.